Navigation Links
Varian Medical Systems Announces Net Orders Growth Estimates for the First Quarter of Fiscal Year 2009
Date:1/12/2009

PALO ALTO, Calif., Jan. 12 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR) today announced that it estimates the company will report net orders growth in the first quarter of fiscal year 2009 in the range of 12 to 13 percent above the year-ago period with gains in all of its major businesses.

Speaking to the financial community at the JP Morgan Healthcare Conference in San Francisco, Tim Guertin, president and CEO of Varian Medical Systems, said that compared to the year-ago quarter, net orders growth will approach 10 to 11 percent in the company's Oncology Systems business, with a 15 to 16 percent increase in the international market and a 6 to 7 percent gain in North America. Compared to the year-ago period, net orders growth is estimated to be about 21 percent in Varian's X-Ray Products business and about 15 percent in its Security and Inspection Products business.

"While there is unprecedented volatility and uncertainty in this economic climate, the solid net orders growth in the first quarter gives us cautious optimism about the prospects for our businesses in 2009," said Guertin.

Investor Conference Call

Varian Medical Systems is scheduled to announce its results for the first quarter of fiscal year 2009 as well as its outlook for the full fiscal year 2009 on Thursday, January 29, 2009 when it will issue a press release at the close of the market and hold a conference call at 2 p.m. The call can be accessed via the company's web site at http://www.varian.com/investor where a replay will be archived for a year. To access the call via telephone, dial 1-866-271-0675 from inside the U.S. or 1-617-213-8892 from outside the U.S. and enter confirmation code 46529406. The replay can be accessed by dialing 1-888-
'/>"/>

SOURCE Varian Medical Systems
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Gene Variant May Hike Womens Risk of Alzheimers
2. Treadmill Desks Combat Obesity Linked to Higher Rates of Ovarian Cancer
3. Biologist finds plant polymerases IV and V are really variants of Polymerase II
4. Obesity Linked to Ovarian Cancer
5. Study links obesity to elevated risk of ovarian cancer
6. Minimizing obesitys impact on ovarian cancer survival
7. Gene Variant Tied to Smokers Risk of Lung Cancer
8. Low Levels of 2 Enzymes in Ovarian Cancer Cells Shortened Survival
9. Fujirebio Diagnostics and Roche Diagnostics Sign Agreement for New Ovarian Cancer Test
10. Stopping ovarian cancer by blocking proteins coded by notorious gene
11. Blocking Oncogene Can Stop Spread of Ovarian Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...Study didn,t answer question of why this is so, ho...ws) -- After a lumpectomy, women with very dense b...the affected breast, a new study shows. , Breas...d risk of developing breast cancer, and experts ha...ssociated with an increased risk of cancer recurre...
(Date:11/9/2009)...,, CAMBRIDGE, Mass., Nov. 9 A...nd capabilities in delivering emergency management...ly awarded contracts to support the work of the Fe...of Regional Operations, the National Commission on...litan Area Transit Authority (WMATA). The value o...
(Date:11/9/2009)...,, WASHINGTON, Nov. 9 /PRNewswire-USNewswire/ -...PA), representing more than 75,000 clinically prac...e United States, applauds the U.S. House of Repres...orm bill, H.R. 3962, the Affordable Health Care fo...that this reform bill will ultimately lower the co...
(Date:11/9/2009)... This release is available in French . , ,... came in twos: male and female. In human bodies tr...molecules from which they are composed. Yet these...tinguishable clusters. Because these complex cell ...ientists have long searched for ways to splice cel...
(Date:11/9/2009)... As many as 10 million people around the world su...niversity in Frankfurt and his coauthors discuss c...cial lens in the current issue of Deutsches rzteb...[43]: 695�). , Blindness is usually due t...e than 600,000 cataract operations are performed e...
Breaking Medicine News(10 mins):Health News:Dense Breasts Raise Risk of Cancer Recurrence 2Health News:Dense Breasts Raise Risk of Cancer Recurrence 3Health News:Abt Associates Expands Emergency Management Support Services To the Federal Government and Washington Metropolitan Area Transit Authority 2Health News:American Academy of Physician Assistants Applauds U.S. House of Representatives for Passing Health Care Reform Bill 2
... with high infection rates has got support from Bi... a stigma attached to the deadly illness and the l...o and so AIDS testing was frowned upon. Accord...er universal testing. As told to journalists ...
...al of a new technology called nanotechnology, it o... more than an eccentric concept //. The term ‘Nano...y small machines from nanometer size units that ar...rnment organizations and multinational companies a...
...ple and natural remedy for reducing the intensity .../ by just eating more fruits and vegetables. They ...in antioxidants, are capable of accelerating and w...s of antioxidants, like carotene and lycopene in t...
...erta confirms the popular myth that Rodeo cowboys ...n whiplash injuries, Dr. Robert Ferrari, clinical ...y of Alberta, has found that conducted the cultura...th Faculty of Agriculture of the University of Alb...
...nducted this study which was self funded. The swee... or sourness of the sweetener. // The researchers ...ked to rate 13 different sweeteners and sweet subs...und sucralose (brand name Splenda), a sweetener de...
... confirmed coliform bacteria and diatoms in some s...Spring Water//, Ltd. For this reason North Countr...ecalling all of its bottled water products. Colif...nitary Code. Coliform bacteria may indicate the pr...
Other Medicine News:Health News:Nanotechnology Promises Huge Medical Benefits 2Health News:Quick Recovery in Rodeo Athletes 2Health News:Sweet, Sweeter and Sweetest 2
(Date:11/9/2009)... TOWN OF HEMPSTEAD, N.Y., Nov. 9 /PRNewswire/ -- ...ice officers and other rescue workers came togethe...ty. Merrick firefighter Brian McCauley was one of ... save his own life. ,, Only in his late 30s, Mc...ndergone surgery and extensive chemotherapy treatm...
(Date:11/9/2009)... PALO ALTO, Calif., Nov. 9 Women,s...t has changed its name to Viveve as it prepares fo... select U.S. markets. ,, "Viveve is a name that...cus on women,s sexual health," said Kerry Pope, Vi...ts for the sole purpose of helping women restore t...
(Date:11/9/2009)... NATICK, Mass., Nov. 9 B...nnounced the launch of its COGNIS® cardiac re...TELIGEN® implantable cardioverter defibrillat... the Japanese Ministry of Health, Labor and Welfar...oval in September. COGNIS and TELIGEN are the res...
Breaking Medicine Technology:The SCOOTER Store Surprises 9/11 First Responder & Merrick Firefighter With Power Chair 2The SCOOTER Store Surprises 9/11 First Responder & Merrick Firefighter With Power Chair 3Women's Sexual Health Company Changes Name in Preparation for Market Entry 2Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 2Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 3Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 4Microbes and their hosts exploring the complexity of symbiosis in DNA and cell biology 9396 1Microbes and their hosts exploring the complexity of symbiosis in DNA and cell biology 9396 2Study shows cancer vaccines led to long term survival for patients with metastatic melanoma 9391 1Study shows cancer vaccines led to long term survival for patients with metastatic melanoma 9391 2Valve Repair First in New England Done With Robotic Device 52959 1Valve Repair First in New England Done With Robotic Device 52959 2Valve Repair First in New England Done With Robotic Device 52959 3
...05, 2007 /PRNewswire/ -- Results from,the primary ...Phase,3 study showed that 77 percent of treatment-...TM) (darunavir) 600 mg tablets with,100 mg ritonav...kground regimen (OBR) of antiretroviral (ARV) agen...at week 48, compared to 68,percent of patients tak...
...INESS WIRE)--Jul 9, 2007 - ZIOPHARM,Oncology, Inc....ta,from an ongoing phase II trial of ZIO-201 (isop...oma patients was presented at the,European Society...,2007 in Lugano, Switzerland. The abstract entitle...Sarcoma," was presented by,Rashmi Chugh, MD, a Pri...
Other Medicine Technology:New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 2New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 3New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 4New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 5New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 6New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 7New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 8Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 2Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 3
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
Medicine Products: